Gw Pharmaceuticals reported $-19677000 in Net Income for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Agios Pharmaceuticals AGIO:US $ -88.77M 2.55M
Alexion Pharmaceuticals ALXN:US $ 636M 100.2M
ALKERMES ALKS:US $ -28.99M 31.35M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Biogen BIIB:US $ 329.2M 119.3M
Biomarin Pharmaceutical BMRN:US $ -36.49M 49.44M
Bluebird Bio BLUE:US $ -216.82M 24.89M
Clovis Oncology CLVS:US $ -67.41M 0.96M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
IONIS PHARMACEUT IONS:US $ -82M 1.12M
Moderna Inc MRNA:US 3.33B 553M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Prothena PRTA:US $ 109.25M 81.6M
Ptc Therapeutics PTCT:US $ -133.62M 15.25M
Puma Biotechnology PBYI:US $ -44.67M 39.57M
Regeneron Pharmaceuticals REGN:US $ 1632.2M 1466.7M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Ultragenyx Pharmaceutical RARE:US $ -73M 49.43M
Vertex Pharmaceuticals VRTX:US $ 851.93M 785M
YTE INCY:US $ 181.74M 32.28M
Zogenix ZGNX:US $ -58M 0.89M